Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1527256 | 0.85 | AOC3 (0.51) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5069157 | 0.85 | AOC3 (0.51) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5069152 | 0.85 | AOC3 (0.51) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8647625 | 0.83 | TAAR1 (0.42) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28473074 | 0.83 | TAAR1 (0.42) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5065117 | 0.82 | SMN1; SMN2 (0.44) | CYP51A1SMN1; SMN2L3MBTL1LMNAADRB1 | |
| SCHEMBL15812308 | 0.81 | AOC3 (0.53) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL17371937 | 0.75 | MEN1 (0.50) | MEN1KMT2ASMN1; SMN2HTTL3MBTL1 | |
| SCHEMBL5065739 | 0.75 | KYNU (0.50) | AOC3KDM4EMEN1KMT2ALMNA | |
| SCHEMBL4347700 | 0.75 | ANPEP (0.40) | MEN1KMT2AHTTL3MBTL1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318947-A1 | Inhibitors of Akt Activity | HEERDING DIRK A | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318947-A1 | Inhibitors of Akt Activity | PI4KB, PIK3CA, AKT2 | CYP51A1 1512/4885AOC3 4778/4885KDM4E 2078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.